In our retrospective cohort of patients with melanoma subjected to NGS, we observed not only a strong correlation between NGS and PCR-based methods for detecting BRAF and NRAS mutations but also revealed instances of falsely identified wild-type cases by PCR, including detection of copy-number gain or amplification mutations. The gene discussed is BRAF; the disease is melanoma.